Back
Verve Therapeutics Stock Predictions
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
1
VERV
Verve Therapeutics
Last Price:
4.60
Seasonality Move:
-24.87%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.Verve Therapeutics Stock Forecast
-
Is Verve Therapeutics Stock Undervalued?
The current Verve Therapeutics [VERV] share price is $4.60. The Score for VERV is 1, which is 98% below its historic median score of 50, and infers higher risk than normal. - VERV is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
Will Verve Therapeutics Stock Go Up Next Year?
Data Unavailable
Verve Therapeutics Stock Rating
Data Unavailable
Verve Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
vervetx.com
52-Week Data
52-Week High:
19.34
52-Week Low:
4.31
Prediction Charts
Market Cap:
389.45M
Price in USD:
4.60
Volume:
1.38M
Beta:
1.79
Technical Analysis
SMA50:
5.37
SMA100:
5.68
SMA200:
7.35
52-Wk Change:
-59.79%
Stock Predictions
-
Is Verve Therapeutics stock public?
Yes, Verve Therapeutics is a publicly traded company. -
What is the Verve Therapeutics stock quote today?
The Verve Therapeutics stock price is 4.60 USD today. -
How to buy Verve Therapeutics stock online?
You can buy Verve Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-4 | 5.95 | 6.04 | 6.17 | 5.62 |
| Nov-5 | 6.19 | 6.38 | 6.77 | 6.14 |
| Nov-6 | 6.45 | 6.42 | 6.81 | 6.28 |
| Nov-7 | 6.41 | 6.36 | 6.64 | 6.02 |
| Nov-8 | 6.36 | 6.31 | 6.39 | 6.15 |
| Nov-11 | 6.43 | 6.42 | 6.75 | 6.26 |
| Nov-12 | 6.33 | 6.43 | 6.50 | 6.21 |
| Nov-13 | 6.51 | 5.79 | 6.68 | 5.78 |
| Nov-14 | 5.75 | 5.38 | 5.83 | 5.37 |
| Nov-15 | 5.44 | 4.79 | 5.44 | 4.78 |
| Nov-18 | 4.85 | 4.50 | 4.92 | 4.48 |
| Nov-19 | 4.49 | 4.84 | 4.93 | 4.49 |
| Nov-20 | 4.84 | 4.55 | 4.84 | 4.48 |
| Nov-21 | 4.55 | 4.60 | 4.69 | 4.44 |
Verve Therapeutics Earnings
Data Unavailable
Verve Therapeutics Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.81 per share, and a decrease next year of $0.48 per share.
* Verve Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.